CINECA IRIS Institutional Research Information System

ZUCCHELLI, GEMMA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 900
EU - Europa 410
AS - Asia 99
AF - Africa 30
SA - Sud America 1
Totale 1.440
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 888
IT - Italia 152
SE - Svezia 108
GB - Regno Unito 42
BG - Bulgaria 40
CN - Cina 36
SG - Singapore 36
CI - Costa d'Avorio 24
DE - Germania 24
FR - Francia 19
AT - Austria 16
VN - Vietnam 12
CA - Canada 11
HK - Hong Kong 6
NG - Nigeria 6
JP - Giappone 5
CH - Svizzera 2
NL - Olanda 2
RU - Federazione Russa 2
CL - Cile 1
IE - Irlanda 1
IN - India 1
JO - Giordania 1
KZ - Kazakistan 1
MX - Messico 1
MY - Malesia 1
PL - Polonia 1
UA - Ucraina 1
Totale 1.440
Salva come PNG Salva come JPEG
Città #
Fairfield 133
Chandler 110
Woodbridge 67
Wilmington 66
Ashburn 57
Seattle 57
New York 50
Houston 45
Cambridge 44
Milan 41
Sofia 40
London 30
Princeton 29
Lawrence 28
Abidjan 24
Florence 23
Ann Arbor 22
Medford 22
Serra 19
Beijing 16
Vienna 16
Frankfurt am Main 12
Pisa 11
Ottawa 10
Bremen 8
Des Moines 8
San Diego 8
Dearborn 7
Hong Kong 6
Lagos 6
Nanjing 6
Rome 6
Seacroft 6
Bergenfield 4
Carrara 4
Norwalk 4
Redwood City 4
Boulder 3
Castel Focognano 3
Kunming 3
Marseille 3
Nanchang 3
Okayama 3
Sassano 3
Agliana 2
Düsseldorf 2
Geneva 2
Guangzhou 2
Hebei 2
Ogden 2
Paris 2
Phoenix 2
Santa Maria A Monte 2
Tokyo 2
Turin 2
Verona 2
Winterswijk 2
Almaty 1
Amman 1
Buffalo 1
Correggio 1
Dong Ket 1
Francavilla Fontana 1
Gallarate 1
Genoa 1
Hanoi 1
Jinan 1
Kells 1
Kingston upon Thames 1
Kuala Lumpur 1
Kyiv 1
Lincoln 1
Mexico City 1
Nagold 1
Pierrefonds 1
Piombino 1
Rivergaro 1
San Francisco 1
Saronno 1
Sheffield 1
Stanford 1
Tianjin 1
Trieste 1
Voghera 1
Wandsworth 1
Warsaw 1
Washington 1
Totale 1.126
Salva come PNG Salva come JPEG
Nome #
TRIPLETE: A randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer 105
Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials 104
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable 92
Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component 85
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenib 83
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer 76
Leadless cardiac pacemaker implant in a patient with two deep brain stimulators: A peaceful cohabitation beyond prejudices 71
Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies 67
Where is the future of cardiac lead extraction heading? 66
Subcutaneus Implantable Defibrillator in an acromegalic pregnant woman for secondary prevention of sudden cardiac death: When (2) technologies save (2) lives 66
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study 60
Trifluridine/Tipiracil (TAS-102) in Refractory Metastatic Colorectal Cancer: A Multicenter Register in the Frame of the Italian Compassionate Use Program 59
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study 52
Standard versus strict stability criteria in radiofrequency paroxysmal atrial fibrillation ablation using ablation index 49
Leadless pacing in the elderly: Never too old for something new 43
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy—a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest 42
Feasibility and long-term effectiveness of a non-apical Micra pacemaker implantation in a referral centre for lead extraction 39
Impact of age and gender on the safety and efficacy of chemotherapy plus bevacizumab in metastatic colorectal cancer: A pooled analysis of TRIBE and TRIBE2 studies 37
Comparison between leadless and transvenous single-chamber pacemaker therapy in a referral centre for lead extraction 37
Micra pacemaker implant after cardiac implantable electronic device extraction: feasibility and long-term outcomes 36
Prognostic and predictive impact of consensus molecular subtypes and CRCAssigner classifications in metastatic colorectal cancer: a translational analysis of the TRIBE2 study 33
Role of pre-procedural CT imaging on catheter ablation in patients with atrial fibrillation: procedural outcomes and radiological exposure 32
Predictors of zero X ray procedures in supraventricular arrhythmias ablation 30
Utility of risk scores to predict adverse events in cardiac lead extraction 30
Leadless technology: A new paradigm for cardiac pacing? 27
Transvenous lead extraction: Efficacy and safety of the procedure in octogenarian patients 26
Safety and efficacy of transvenous mechanical lead extraction in patients with abandoned leads 25
Leadless pacing in a patient with superior vena cava syndrome undergoing lead extraction and percutaneous angioplasty 23
Totale 1.495
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.596
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.596
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201932 0 0 0 0 0 0 0 0 0 0 20 12
2019/2020332 27 24 20 20 38 36 44 38 36 18 27 4
2020/2021172 7 14 14 11 1 26 16 15 24 10 12 22
2021/2022224 0 1 2 0 28 32 35 3 12 18 31 62
2022/2023445 53 86 42 24 44 55 3 27 70 2 38 1
2023/2024223 23 28 49 16 32 48 16 6 5 0 0 0
Totale 1.495